Duplicate LLOQ and ULOQ [Bioanalytics]

posted by Helmut Homepage – Vienna, Austria, 2012-01-20 19:02 (4882 d 04:36 ago) – Posting: # 7983
Views: 5,054

Dear Ohlbe!

❝ ❝ ❝ What most people do is that they only use one of the two replicates of the LLOQ and ULOQ samples. Usually the first replicate is used,…

❝ ❝

❝ ❝ Really most people?


❝ In my experience, yes. I mean, most people analysing only the first and last samples in duplicate.


Ah, now I get your point!

❝ […] if you consider you need duplicate analysis to get a correct fit, then you should also analyse the subject samples in duplicate...


From a statistical point of view the best weighting scheme would be 1/s² (1/x or 1/x² are crude attempts to deal with multiplicative error). I don’t want to start a discussion whether it makes sense to calculate s² from n=2. :-D But there is a drawback: 1/s² can only be used for pretty ‘stable’ methods where one would never drop any calibrator.

❝ Some other labs analyse the whole curve in duplicate, once at the start of the run and once at the end, to compensate for possible drifts. Personally if there is a drift I would rather shorten the run... But I think that's a discussion we had previously on the forum.


Yes…

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,681 registered users;
31 visitors (0 registered, 31 guests [including 20 identified bots]).
Forum time: 00:38 CEST (Europe/Vienna)

EMEA. The European Medicines Evaluation Agency.
The drug regulatory agency of the European Union.
A statistician-free zone.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5